Central Pharma provides vague information to shareholders: Auditor
In the financial statement, the company has written off an inventory of Tk48 crore, but it did not provide supporting documents regarding the matter.
In the financial statement, the company has written off an inventory of Tk48 crore, but it did not provide supporting documents regarding the matter.